Brief: Heat Biologics Terminates Collaboration With University Of Miami For Development Of A Covid-19 Point Of Care Diagnostic
28/04/2020 14:35
April 28 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS - TERMINATED ITS COLLABORATION WITH
UNIVERSITY
OF MIAMI FOR DEVELOPMENT OF A COVID-19 POINT OF CARE DIAGNOSTIC
* HEAT BIOLOGICS INC - HAS ALSO FILED A PROVISIONAL PATENT
APPLICATION FOR ITS OWN COVID-19 DIAGNOSTIC TEST
Source : (https://bit.ly/2KH8c61)
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company